Cannabis Science and Technology™ Added William Z. Levine, D.D.S., to Editorial Advisory Board

Cannabis Science and Technology™ is a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation. The company announced the addition of William Z. Levine, D.D.S., to its editorial advisory board.

Cannabis Science and Technology™ is a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation. The magazine is accompanied by an online component and provides relevant information and tutorials for all members of the cannabis industry. Cannabis Science and Technology™ is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

“We look forward to having Dr. Levine joining the Cannabis Science and Technology™ advisory board,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of Cannabis Science and Technology™. “His experience and contributions will be a great asset to our editorial staff as we continue to deliver unprecedented content to our readers.”

Levine is the founder of Izun Pharmaceuticals Corporation, a biopharmaceutical company specializing in botanical medicine. This area of specialty pharma develops pharmaceutical and health care products from plant-based sources. Levine, who received his D.D.S. degree and specialty training in periodontics from Columbia University, initially utilized this background to formulate novel oral care products to treat periodontal disease more effectively. Izun has also developed wound care products, oncology support products, and products targeting women’s health care.

Subsequently, recognizing the Izun expertise in botanicals, Levine applied this knowledge to the cannabis plant and established CannRx. In a short time, CannRx has developed novel targeted formulations, highly effective drug delivery systems specifically designed for cannabis, and completely new extraction systems.

As a member of the advisory board, Levine will work closely with the editorial team and the existing 16 board members to recommend topics, solicit and provide content, and share breaking news and information on the latest happenings in the cannabis industry.